NCT07175857 (LYVENDO) is a NA clinical trial of Lyv Endo app in Endometriosis, sponsored by Lyv Healthcare.

Who is sponsoring NCT07175857?

NCT07175857 is sponsored by Lyv Healthcare.

What drugs are being tested in NCT07175857?

Interventions in NCT07175857: Lyv Endo app.

What condition does NCT07175857 study?

NCT07175857 studies Endometriosis.

Is NCT07175857 still recruiting?

NCT07175857 is currently recruiting now. Last updated 16 September 2025.

Last reviewed 2025-09-16 · How we verify

NCT07175857: LYVENDO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Efficacy of an Innovative Digital Therapeutic Medical Device, Lyv Endo, for the Management of Patients With Endometriosis

Recruiting now NA Last updated 16 September 2025

What this trial tests

NA trial testing Lyv Endo app in Endometriosis in 304 participants. Currently enrolling.

Timeline

21 July 2025

Primary endpoint
31 August 2026

31 August 2026

Quick facts

Lead sponsor	Lyv Healthcare
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	304
Start date	21 July 2025
Primary completion	31 August 2026
Estimated completion	31 August 2026
Sites	6 locations across France

Drugs / interventions tested

Lyv Endo app

Conditions studied

Endometriosis — all drugs for Endometriosis →

Sponsor

Lyv Healthcare

Who can join

18 and older, female only, with Endometriosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this clinical study is to evaluate the clinical impact of using an innovative digital therapeutic device on the quality of life of patients with endometriosis. The working hypothesis is that the therapeutic digital medical device Lyv Endo may improve quality of life and reduce symptom intensity by enhancing patient engagement in the management of their condition. This justifies the need to evaluate the effect of Lyv Endo as a complement to standard medical care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

NCT06559852 — The Impact of Yoga on Endometriosis-Related Pain · NA · recruiting
NCT07393295 — Efficacy and Tolerability of TENS in Endometriosis-related Pain · NA · recruiting
NCT07134023 — Educational Program for the Multidisciplinary Support of Patients With Endometriosis · NA · recruiting
NCT07240883 — ENDO1000 - A UK-wide Endometriosis Research Project · recruiting
NCT06974773 — Remote Electrical Stimulation as a Long-term Intervention for Endometriosis Flare Ups · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07175857 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lyv Healthcare
Last refreshed: 16 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07175857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing